Tevogen Stock Surges on Expanded Microsoft AI Collaboration

Seeking Alpha

01-25

Tevogen Bio (NASDAQ:TVGN) stock jumped nearly 26% post-market after the company announced it has expanded its relationship with Microsoft (NASDAQ:MSFT) to broaden their AI-focused collaboration and build its PredicTcell technology for predictive precision T cell targeting.

The Tevogen.AI initiative will integrate Microsoft's AI tools and Azure cloud platform to expand Tevogen's (NASDAQ:TVGN) ExacTcell preclinical pipeline. The initiative will also aim to develop proprietary algorithms to decode HLA-T cell interactions, according to a statement.

The company added it is also investigating potential treatments for HPV and identifying cytotoxic T cell targets to select for a clinical trial for its first oncology drug candidate, TVGN 920.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/1132878034"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1132878034\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/1132878034?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-01-25 11:15","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1132878034","market":"us","top_or_hot":-1,"title":"Tevogen Stock Surges on Expanded Microsoft AI Collaboration","media":"Seeking Alpha","content":"<html><head></head><body><p>Tevogen Bio (NASDAQ:TVGN) stock jumped nearly 26% post-market after the company announced it has expanded its relationship with Microsoft (NASDAQ:MSFT) to broaden their AI-focused collaboration and build its PredicTcell technology for predictive precision T cell targeting.</p><p class=\"t-img-caption\"><img src=\"https://community-static.tradeup.com/news/7aa6cab6471e2c39405d9d453c079811\" tg-width=\"883\" tg-height=\"622\"/></p><p style=\"text-align: left;\">The Tevogen.AI initiative will integrate Microsoft&#39;s AI tools and Azure cloud platform to expand Tevogen&#39;s (NASDAQ:TVGN) ExacTcell preclinical pipeline. The initiative will also aim to develop proprietary algorithms to decode HLA-T cell interactions, according to a statement.</p><p style=\"text-align: left;\">The company added it is also investigating potential treatments for HPV and identifying cytotoxic T cell targets to select for a clinical trial for its first oncology drug candidate, TVGN 920.</p></body></html>","source":"lsy1728464409321","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tevogen Stock Surges on Expanded Microsoft AI Collaboration</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTevogen Stock Surges on Expanded Microsoft AI Collaboration\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-01-25 11:15 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/4398655-tevogen-stock-rallies-on-expanded-microsoft-ai-collaboration><strong>Seeking Alpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Tevogen Bio (NASDAQ:TVGN) stock jumped nearly 26% post-market after the company announced it has expanded its relationship with Microsoft (NASDAQ:MSFT) to broaden their AI-focused collaboration and ...</p>\n\n<a href=\"https://seekingalpha.com/news/4398655-tevogen-stock-rallies-on-expanded-microsoft-ai-collaboration\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"MSFT","symbol_name":"微软","start_time":0,"source_url":"https://seekingalpha.com/news/4398655-tevogen-stock-rallies-on-expanded-microsoft-ai-collaboration","article_id":"1132878034","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1132878034","pubTimestamp":1737774900,"columns":[],"sourceInfo":{"source_id":"lsy1728464409321","name":"Seeking Alpha"},"weMediaInfo":null,"summary":"Tevogen Bio  stock jumped nearly 26% post-market after the company announced it has expanded its relationship with Microsoft  to broaden their AI-focused collaboration and build its PredicTcell technology for predictive precision T cell targeting.The Tevogen.AI initiative will integrate Microsoft's AI tools and Azure cloud platform to expand Tevogen's  ExacTcell preclinical pipeline. The initiative will also aim to develop proprietary algorithms to decode HLA-T cell interactions, according to a ","collect":0,"end_time":0,"defaultTopTitle":"seekingalpha.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"MSFT":"微软","TVGN":"Tevogen Bio Holdings"},"translate_title":"Tevogen股价因微软人工智能合作扩大而飙升","themeId":"3438f2c5d0af3ac7098ae251e297d7d5","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"MSFT":1.1,"TVGN":1.1},"content_text":"Tevogen Bio (NASDAQ:TVGN) stock jumped nearly 26% post-market after the company announced it has expanded its relationship with Microsoft (NASDAQ:MSFT) to broaden their AI-focused collaboration and build its PredicTcell technology for predictive precision T cell targeting.The Tevogen.AI initiative will integrate Microsoft's AI tools and Azure cloud platform to expand Tevogen's (NASDAQ:TVGN) ExacTcell preclinical pipeline. The initiative will also aim to develop proprietary algorithms to decode HLA-T cell interactions, according to a statement.The company added it is also investigating potential treatments for HPV and identifying cytotoxic T cell targets to select for a clinical trial for its first oncology drug candidate, TVGN 920.","kind":"news","is_publish_news":true,"is_publish_highlight":true,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"code":"91000000","status":"200"}}}